1. Academic Validation
  2. Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors

Structure-activity relationship and liver microsome stability studies of pyrrole necroptosis inhibitors

  • Bioorg Med Chem Lett. 2008 Jun 1;18(11):3219-23. doi: 10.1016/j.bmcl.2008.04.048.
Xin Teng 1 Heather Keys Junying Yuan Alexei Degterev Gregory D Cuny
Affiliations

Affiliation

  • 1 Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham & Women's Hospital and Harvard Medical School, 65 Landsdowne Street, Cambridge, MA 02139, USA.
Abstract

Necroptosis is a regulated caspase-independent cell death pathway resulting in morphology reminiscent of passive non-regulated necrosis. Several diverse structure classes of Necroptosis inhibitors have been reported to date, including a series of [1,2,3]thiadiazole benzylamide derivatives. However, initial evaluation of mouse liver microsome stability indicated that this series of compounds was rapidly degraded. A structure-activity relationship (SAR) study of the [1,2,3]thiadiazole benzylamide series revealed that increased mouse liver microsome stability and increased Necroptosis inhibitory activity could be accomplished by replacement of the 4-cyclopropyl-[1,2,3]thiadiazole with a 5-cyano-1-methylpyrrole. In addition, the SAR and the cellular activity profiles, utilizing different cell types and necroptosis-inducing stimuli, of representative [1,2,3]thiadiazole and pyrrole derivatives were very similar suggesting that the two compound series inhibit Necroptosis in the same manner.

Figures